Crescendo Biologics appoints Dr Kevin Johnson as chairman
November 17, 2015Research and Development
Crescendo Biologics, the drug discovery and developer of Humabody VH therapeutics, has announced the appointment of Dr Kevin Johnson as non-executive …
Catalent forced to suspend production after possible employee product sabotage
November 17, 2015Manufacturing and Production
Catalent has been forced to halt production at one of its French softgel capsule factories after the US-based manufacturer identified …
AbbVie rules out joining the biosimilars bandwagon
November 17, 2015Manufacturing and Production, Research and Development
AbbVie says it has ruled out moving into the biosimilars market to stave off competition once its blockbuster drug Humira …
FDA approves ‘first of its kind’ blood cancer drug
November 17, 2015Manufacturing and Production, Research and Development
The FDA has approved Genmab’s drug Darzalex for patients with multiple myeloma. Darzalex (daratumumab) is the first human CD38 monoclonal antibody …
DJM PAN Unlimited adds client services director
November 17, 2015Manufacturing and Production, Sales and Marketing
Wyndham Clark has joined the board of DJM PAN Unlimited as client services director. Previously, Clark was client services director …
NICE rejects Roche’s Kadcyla for NHS; price still too high
November 17, 2015Manufacturing and Production, Sales and Marketing Cancer Drugs Fund, Kadcyla, NHS England, NICE, Roche
NICE has published final draft guidance on Roche’s Kadcyla as a breast cancer treatment, deciding that the drug’s price remains …
Featured Market Report: Type 2 Diabetes – Epidemiology Forecast to 2024
November 16, 2015Manufacturing and Production, Research and Development diabetes, market reports
Diabetes is one of the most common non-communicable diseases worldwide and is an escalating public health problem globally, with an …
Pharma boss in sexism storm
November 16, 2015Immuno Biotech CEO David Noakes has been found guilty of sexual discrimination after making notes on the job application of …
FDA approves Baxalta Haemophilia A treatment
November 16, 2015Manufacturing and Production, Research and Development, Sales and Marketing
The US FDA has approved Baxalta’s twice-weekly therapy Adynovate for use in adults and adolescents, aged 12 years plus, with …
Former Health Secretary Andrew Lansley takes on Roche advisory role
November 16, 2015Medical Communications, Sales and Marketing
Former UK health secretary Andrew Lansley has taken on work as an advisor to Roche in the midst of ongoing …
Novo Nordisk invests $20m in diabetes research following study
November 16, 2015Research and Development, Sales and Marketing
Novo Nordisk has unveiled plans to combat urban diabetes in a $20 million investment offering expert resources and research funds …
Amgen’s Humira biosimilar succeeds in Phase III arthritis study
November 16, 2015Research and Development, Sales and Marketing Amgen, Humira
Amgen says its Humira (adalimumab) biosimilar candidate ABP 501 proved its clinical equivalence to Abbvie’s blockbuster drug in a head-to-head …
Takeda UK strengthens its senior leadership team
November 16, 2015Medical Communications, Sales and Marketing
Takeda UK is bolstering its Medical and Human Resources functions as Takeda continues to develop its expertise in the Specialty …
AstraZeneca earns ‘speedy’ FDA approval for lung cancer drug
November 13, 2015AZD9291, AstraZeneca, Tagrisso, lung cancer
The FDA has approved AstraZeneca’s new lung cancer drug Tagrisso, in a record two and half years from development, under …
Perrigo rejects $26 billion hostile Mylan takeover bid
November 13, 2015Medical Communications, Sales and Marketing Mylan, Perrigo, mergers and acquisitions
Perrigo has rejected Mylan’s hostile $26 billion bid after a 60% majority of shareholders were unconvinced by the terms by …
FDA expands Gilead’s Harvoni indications for Hep C
November 13, 2015Sales and Marketing Gilead, Gilead Sciences, harvoni, ledipasvir-sofosbuvir
Gilead’s Harvoni has been approved by the FDA for expanded use in patients with genotypes 4, 5 and 6 chronic …
New appointments for AstraZeneca’s Mene Pangalos
November 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Dr Mene Pangalos, executive vice president of the IMED Biotech Unit at AstraZeneca UK, has accepted two prestigious appointments that …
Google and AHA to fund $50m cardiovascular disease project
November 13, 2015Medical Communications, Research and Development American Heart Association, cardiovascular disease, google, heart disease
The American Heart Association and Google Life Sciences have announced a joint research collaboration to bring ‘unconventional thinking’ to the …
Patents prompting ‘rebirth’ of innovation in industry
November 13, 2015Medical Communications innovation, patents, pharma
Seven pharma companies have been rated among the world’s 100 most innovative companies, according to Thomson Reuters.The business intelligence firm …
Roche manufacturing restructure means EU, US jobs cuts
November 13, 2015Manufacturing and Production, Medical Communications Roche, job cuts, job losses, manufacturing, production, redundancies, restructure
Roche has announced plans to restructure its manufacturing network for small molecules, in a move that will see it mothball …
Latest content
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
Danish medical cannabis use rises as regulator reports no new safety signals
